Correlation Between Kronos Bio and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and Foghorn Therapeutics, you can compare the effects of market volatilities on Kronos Bio and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and Foghorn Therapeutics.
Diversification Opportunities for Kronos Bio and Foghorn Therapeutics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Kronos and Foghorn is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Kronos Bio i.e., Kronos Bio and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Kronos Bio and Foghorn Therapeutics
Given the investment horizon of 90 days Kronos Bio is expected to generate 0.45 times more return on investment than Foghorn Therapeutics. However, Kronos Bio is 2.2 times less risky than Foghorn Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 94.00 in Kronos Bio on December 27, 2024 and sell it today you would lose (11.00) from holding Kronos Bio or give up 11.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Kronos Bio vs. Foghorn Therapeutics
Performance |
Timeline |
Kronos Bio |
Foghorn Therapeutics |
Kronos Bio and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kronos Bio and Foghorn Therapeutics
The main advantage of trading using opposite Kronos Bio and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.Kronos Bio vs. Day One Biopharmaceuticals | Kronos Bio vs. Mirum Pharmaceuticals | Kronos Bio vs. Rocket Pharmaceuticals | Kronos Bio vs. Avidity Biosciences |
Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Money Managers Screen money managers from public funds and ETFs managed around the world |